Raymond James & Associates Viatris Inc Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Viatris Inc stock. As of the latest transaction made, Raymond James & Associates holds 1,406,036 shares of VTRS stock, worth $17.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,406,036

Previous 1,326,542 5.99%

Holding current value

$17.6 Million

Previous $14.1 Million 15.76%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$10.32 - $12.13 $820,378 - $964,262	79,494 Added 5.99%	1,406,036 $16.3 Million
Q2 2024 Jul 19, 2024	SELL	$10.05 - $12.02 $106,499 - $127,375	-10,597 Reduced 0.79%	1,326,542 $14.1 Million
Q1 2024 Apr 22, 2024	BUY	$11.27 - $13.53 $1.94 Million - $2.33 Million	171,936 Added 14.76%	1,337,139 $16 Million
Q4 2023 Jan 16, 2024	SELL	$8.77 - $10.85 $1.38 Million - $1.71 Million	-157,733 Reduced 11.92%	1,165,203 $12.6 Million
Q3 2023 Oct 24, 2023	SELL	$9.59 - $11.35 $346,064 - $409,576	-36,086 Reduced 2.66%	1,322,936 $13 Million
Q2 2023 Jul 25, 2023	BUY	$9.02 - $10.29 $2.71 Million - $3.09 Million	300,565 Added 28.4%	1,359,022 $13.6 Million
Q1 2023 Apr 14, 2023	BUY	$9.2 - $12.26 $430,596 - $573,817	46,804 Added 4.63%	1,058,457 $10.2 Million
Q4 2022 Feb 08, 2023	SELL	$8.72 - $11.56 $1.8 Million - $2.38 Million	-205,985 Reduced 16.92%	1,011,653 $11.3 Million
Q3 2022 Oct 25, 2022	SELL	$8.48 - $11.13 $664,297 - $871,890	-78,337 Reduced 6.04%	1,217,638 $10.4 Million
Q2 2022 Aug 12, 2022	SELL	$9.95 - $12.27 $2.61 Million - $3.22 Million	-262,285 Reduced 16.83%	1,295,975 $13.6 Million
Q1 2022 May 11, 2022	BUY	$9.81 - $15.4 $2.43 Million - $3.81 Million	247,563 Added 18.89%	1,558,260 $17 Million
Q4 2021 Feb 08, 2022	BUY	$12.09 - $14.68 $4.56 Million - $5.54 Million	377,140 Added 40.4%	1,310,697 $17.7 Million
Q3 2021 Nov 02, 2021	SELL	$13.25 - $15.13 $350,489 - $400,218	-26,452 Reduced 2.76%	933,557 $12.7 Million
Q2 2021 Aug 11, 2021	SELL	$12.97 - $16.15 $846,577 - $1.05 Million	-65,272 Reduced 6.37%	960,009 $13.7 Million
Q1 2021 May 14, 2021	BUY	$13.59 - $18.54 $303,464 - $413,998	22,330 Added 2.23%	1,025,281 $14.3 Million
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $14.3 Million - $18.8 Million	1,002,951 New	1,002,951 $18.8 Million

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Viatris Inc Transaction History